Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Cogent Biosciences Relocates Headquarters to BXP’s 180 CityPoint
Cogent Biosciences, Inc. has signed a 31,518-square-foot lease at 180 CityPoint, a Class A office and life sciences building owned and operated by BXP in Waltham, MA. Cogent’s new space will serve as the company’s corporate headquarters in a relocation from 275 Wyman St. as it prepares to commercialize its first product.
Cushman & Wakefield’s Michael O’Leary, Kevin McNamara, Thomas Ashe and Ross Gaudet represented Cogent Biosciences. BXP was self-represented by Pat Mulvihill, SVP of leasing, and Casey Torto, leasing manager for BXP’s Boston region.
“This headquarters lease underscores the shift of innovative biotech companies coming to Waltham, which offers the high-quality space and accessibility that companies primarily once looked for in Cambridge,” said McNamara. “Cogent will benefit from a state-of-the-art environment that supports the firm’s culture, recruitment and long-term success.”
BXP recently signed Amplitude Vascular Systems at 180 CityPoint, relocating from the Seaport District into 38,000 square feet in Waltham.
Industry leaders from CommonSpirit, Meridian, Adventist Health and Anchor Health will share insights shaping the future of healthcare real estate. Be part of the conversation at Connect Healthcare Real Estate, October 14–15 in Irvine: www.ConnectHealthcareCRE2025.com
- ◦Lease
